Market growth factors-
- Increasing prevalence of cancer & CVD.
- Rising volume of CT & MRI examinations.
- Regulatory approval of a growing number of contrast agents
Global market size-
According to research report the contrast media market is expected to reach $6.0 billion by 2024, growing at a CAGR of 3.8% during the forecast period.
Leading Players-
GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).
Top Segments-
Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media. In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry. The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.
Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast agent market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.
For Details, Download PDF Brochure
Geographic Overview -
North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast agent market study. North American market is expected to account for the largest share of the global Contrast Media Contrast Agent Market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period.